CELL ONCOL 润色咨询

CELLULAR ONCOLOGY

出版年份:暂无数据 年文章数:470 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:28.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=ca261373, cover=https://img.medsci.cn/images/journal/cover/2021/XgI_202109271314388410.jpg, fullname=CELLULAR ONCOLOGY, abbr=CELL ONCOL, pyear=暂无数据, frequence=Bimonthly, articleNumbers=470, citedSelf2015=28.1, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2211-3428, greenSci=https://www.greensci.net/search?kw=2211-3428, scijournal=https://www.scijournal.org/impact-factor-of-CELL-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=7.551, medsciHotlight=8.264, medsciHotlight5year=7.45408, citescore=0.0, hIndex=40, impactFactor=6.6, orgnization=Springer Netherlands, orgnizationUrl=http://springerlink.com, country=Germany, countryCn=德国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=http://cellularoncology.eu/, websiteHits=6374, guideForAuthor=null, guideForAuthorHits=22, submitWebsite=https://www.editorialmanager.com/ceon/default.aspx, submitWebsiteHits=3947, content=Published by IOS Press. ISSN: 1570-5870.<br /><br />Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype - phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the management of cancer patients. Cellular Oncology publishes original papers, rapid communications, topical reviews, technical notes, special reports and letters., totalCites=3107, brief=CELL ONCOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=病理学" >病理学</a></strong>”子行业的优秀级杂志, articleType=论著,综述各类型文章都接收, medsciHeat=黑红, medsciComment=CELL ONCOL在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=ca261373'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=13), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=6), ImpactFactorTagDto(id=718, tagName=胰腺癌, createdHits=1), ImpactFactorTagDto(id=3184, tagName=综述, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.79), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.18), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.42), GetImpactFactorCiteScoreListResponse(year=2019, citescore=8.5), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=9.746), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=8.371), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=9.233), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=9.775), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=7.551)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=54/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=28/165), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=49/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CELL BIOLOGY, rank=Q4), GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3), GetImpactFactorCiteScoreGradeResponse(smallClass=PATHOLOGY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3428[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CELLULAR ONCOLOGY[ta], article_number=86, article_number_cn=30, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CELL ONCOL/CELLULAR ONCOLOGY
ISSN
2211-3428
影响指数话题
预警等级
MedSci期刊指数
7.551 (MedSci实时期刊指数) | 7.45408 (5年期刊指数)
CiteScore值
0.0
h-index
40
h5-median
暂无数据
出版社/管理机构
杂志由 Springer Netherlands 出版或管理
出版国家/地区
Germany 德国
出版周期
Bimonthly
出版年份
暂无数据
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
CELL BIOLOGY Q4
ONCOLOGY Q3
PATHOLOGY Q2
中科院分区
大类:医学 2区
小类:医学 2 区